AZD1656 is a potent, selective, orally active glucokinase activator. AZD1656 has potential for type 2 diabetes research.

 

Brand: BCM

 

Target: Glucokinase

 

Signaling Pathways: Metabolism

 

Boiling Point: 635.0±55.0 °C at 760 mmHg

 

Flashing Point: 337.8±31.5 °C

 

pKa: 10.84±0.70(Predicted)

 

Solubility: Soluble in DMSO; soluble in Ethanol. Insoluble in Water.

 

GHS: GHS08, GHS06

 

Isomeric SMILES: CC1=CN=C(C=N1)NC(=O)C2=CC(=CC(=C2)O[C@@H](C)COC)OC3=NC=C(N=C3)C(=O)N4CCC4  

 

InChIKey: FJEJHJINOKKDCW-INIZCTEOSA-N  

 

InChI: InChI=1S/C24H26N6O5/c1-15-10-27-21(12-25-15)29-23(31)17-7-18(34-16(2)14-33-3)9-19(8-17)35-22-13-26-20(11-28-22)24(32)30-5-4-6-30/h7-13,16H,4-6,14H2,1-3H3,(H,27,29,31)/t16-/m0/s1

 

Attribute
[Chem Name]	3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(2S)-1-methoxypropan-2-yl]oxy-N-(5-methylpyrazin-2-yl)benzamide
[Synonym]	AZD1656; AZD-1656
[CAS No.]	919783-22-5
[MDL No.]	MFCD28386282
[Formula]	C24H26N6O5
[Molecular]	478.5
[Form]	Solid powder
[Storage]	Sealed in dry. Stored at -20°C

Goods Tag